Trial Outcomes & Findings for VOICE: Values and Options in Cancer Care (NCT NCT01485627)

NCT ID: NCT01485627

Last Updated: 2019-01-10

Results Overview

We audio recorded the first physician visit after the coaching session (for intervention) or after study entry (control).The primary outcome was a composite of 4 pre-specified communication measures: 1. engaging patients in consultations, responding to patients' emotions, informing patients about prognosis and treatment choices and balanced framing of decisions. Coding of the 4 measures was performed by teams of trained university students who were audited continuously and blinded to study hypotheses and group assignment. We transformed each of the 4 component scores to z scores based on the pre-randomization phase sample means (SDs): z = (Raw Score - Pre-randomization Phase Mean)/Pre-randomization Phase SD. The 4-component z-scores were averaged to form the primary outcome. A higher Z score indicates better communication. The maximum possible Z-score ranged from -0.69 to 20.08.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

485 participants

Primary outcome timeframe

3 years

Results posted on

2019-01-10

Participant Flow

54 physicians were assessed for eligibility. Of these 2 were ineligible and 9 refused participation. 43 physicians were included in the pre-randomized phase and of these 2 withdrew and 3 did not enroll enough patients. Patients from 38 physicians were included for the cluster randomized clinical trial phase of the study.

233 caregivers and 316 patients were consented. 204 caregivers were allocated and 127 of them were bereaved. 24 caregivers failed screening and 5 withdrew during screening. 26 patients failed screening and 9 withdrew during screening.

Unit of analysis: physicians

Participant milestones

Participant milestones
Measure
Intervention: Communication
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control: Usual Care
Patients will receive usual care
Overall Study
STARTED
244 19
241 19
Overall Study
Allocated Caregivers: Total
105 19
99 19
Overall Study
Bereaved Caregivers: Total
63 19
64 19
Overall Study
Bereaved Caregivers: 1 Month
51 19
51 19
Overall Study
Bereaved Caregivers: 2 Month Completed
49 19
52 19
Overall Study
Bereaved Caregivers: 7 Month Completed
48 19
49 19
Overall Study
COMPLETED
178 19
184 19
Overall Study
NOT COMPLETED
66 0
57 0

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention: Communication
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control: Usual Care
Patients will receive usual care
Overall Study
Patient withdrew
6
5
Overall Study
Patient died
3
1
Overall Study
Patient lost to followup
0
1
Overall Study
Caregiver withdrew
3
3
Overall Study
Caregiver lost to follow up
11
12
Overall Study
Caregiver died
1
0
Overall Study
caregiver was not bereaved
42
35

Baseline Characteristics

Region of enrollment for caregivers only

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention: Communication Training
n=180 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control: Usual Care
n=188 Participants
Patients will receive usual care
Total
n=368 Participants
Total of all reporting groups
Region of Enrollment
United States
50 participants
n=50 Participants • Region of enrollment for caregivers only
53 participants
n=53 Participants • Region of enrollment for caregivers only
265 participants
n=265 Participants • Region of Enrollment for patients only
Age, Categorical
<=18 years
0 Participants
n=50 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
0 Participants
n=53 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
0 Participants
n=103 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
Age, Categorical
Between 18 and 65 years
21 Participants
n=50 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
27 Participants
n=53 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
48 Participants
n=103 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
Age, Categorical
>=65 years
29 Participants
n=50 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
26 Participants
n=53 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
55 Participants
n=103 Participants • Age categorical was collected for the bereaved caregivers only who completed the month 2 and/or month 7 assessment.
Age, Continuous
64.2 years
STANDARD_DEVIATION 11.7 • n=130 Participants • Age continuous was collected for the patients.
64.5 years
STANDARD_DEVIATION 11 • n=135 Participants • Age continuous was collected for the patients.
64.4 years
STANDARD_DEVIATION 11.4 • n=265 Participants • Age continuous was collected for the patients.
Sex: Female, Male
patients · Female
76 Participants
n=130 Participants • The overall number of participants is the total of caregivers and patients for each arm.
70 Participants
n=135 Participants • The overall number of participants is the total of caregivers and patients for each arm.
146 Participants
n=265 Participants • The overall number of participants is the total of caregivers and patients for each arm.
Sex: Female, Male
patients · Male
54 Participants
n=130 Participants • The overall number of participants is the total of caregivers and patients for each arm.
65 Participants
n=135 Participants • The overall number of participants is the total of caregivers and patients for each arm.
119 Participants
n=265 Participants • The overall number of participants is the total of caregivers and patients for each arm.
Sex: Female, Male
Caregivers · Female
25 Participants
n=50 Participants • The overall number of participants is the total of caregivers and patients for each arm.
29 Participants
n=53 Participants • The overall number of participants is the total of caregivers and patients for each arm.
54 Participants
n=103 Participants • The overall number of participants is the total of caregivers and patients for each arm.
Sex: Female, Male
Caregivers · Male
25 Participants
n=50 Participants • The overall number of participants is the total of caregivers and patients for each arm.
24 Participants
n=53 Participants • The overall number of participants is the total of caregivers and patients for each arm.
49 Participants
n=103 Participants • The overall number of participants is the total of caregivers and patients for each arm.
Race (NIH/OMB)
patients · American Indian or Alaska Native
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
patients · Asian
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
patients · Native Hawaiian or Other Pacific Islander
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
patients · Black or African American
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
patients · White
116 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
119 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
235 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
patients · More than one race
0 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
patients · Unknown or Not Reported
14 Participants
n=130 Participants • Overall baseline participants includes both the patients and caregivers
16 Participants
n=135 Participants • Overall baseline participants includes both the patients and caregivers
30 Participants
n=265 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · American Indian or Alaska Native
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · Asian
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · Native Hawaiian or Other Pacific Islander
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · Black or African American
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · White
44 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
46 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
90 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · More than one race
0 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
0 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers
Race (NIH/OMB)
Caregivers · Unknown or Not Reported
6 Participants
n=50 Participants • Overall baseline participants includes both the patients and caregivers
7 Participants
n=53 Participants • Overall baseline participants includes both the patients and caregivers
13 Participants
n=103 Participants • Overall baseline participants includes both the patients and caregivers

PRIMARY outcome

Timeframe: 3 years

Population: This outcome measure was assessed in patients only.

We audio recorded the first physician visit after the coaching session (for intervention) or after study entry (control).The primary outcome was a composite of 4 pre-specified communication measures: 1. engaging patients in consultations, responding to patients' emotions, informing patients about prognosis and treatment choices and balanced framing of decisions. Coding of the 4 measures was performed by teams of trained university students who were audited continuously and blinded to study hypotheses and group assignment. We transformed each of the 4 component scores to z scores based on the pre-randomization phase sample means (SDs): z = (Raw Score - Pre-randomization Phase Mean)/Pre-randomization Phase SD. The 4-component z-scores were averaged to form the primary outcome. A higher Z score indicates better communication. The maximum possible Z-score ranged from -0.69 to 20.08.

Outcome measures

Outcome measures
Measure
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control
n=135 Participants
Patients will receive usual care
Mean Patient-centered Communication in Advanced Cancer Score
0.16 standardized score on a scale
Standard Deviation 0.81
-0.01 standardized score on a scale
Standard Deviation 0.66

SECONDARY outcome

Timeframe: 7 months

Population: This instrument was used with caregivers only.

The prolonged grief (PG-13) instrument was used to measure prolonged grief. The tool is a sum of ten items that measure separation distress, duration of grief, cognitive, emotional, and behavioral symptoms and impairment criterion. The range of the score is 10-50 with higher scores indicating more severe symptoms.

Outcome measures

Outcome measures
Measure
Intervention
n=48 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control
n=49 Participants
Patients will receive usual care
Caregiver Mean Prolonged Grief Symptoms as Measured by PG-13
19.3 units on a scale
Standard Deviation 5.9
20.6 units on a scale
Standard Deviation 6.8

SECONDARY outcome

Timeframe: 3 years

Population: This outcome measure was assessed in patients only.

Patients and physicians were asked what the likelihood of survival in 2 years would be for the patient. They chose from 0, 10, 25, 50, 75, 90, 100% chance of survival in two years. A value of 0-6 was assigned to each pair of data. 0 indicating no difference in the reported value between patient and physician and 6 indicating the largest difference. For example if the physician said 100% and the patient said 0% the score was 6. The mean scores were reported by arm.

Outcome measures

Outcome measures
Measure
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control
n=135 Participants
Patients will receive usual care
Aim 1b&c Mean Difference in Reported Expectation of Survival in 2 Years Between Patients and Physicians
2.2 units on a scale
Standard Deviation 1.5
2.5 units on a scale
Standard Deviation 1.6

SECONDARY outcome

Timeframe: 3 years

Population: This outcome measure was assessed in patients only.

Original McGill quality of life and the FACT-G assessment tools were used. For the McGill tool scores range from 1 to 10 with higher scores indicating better outcome. For FACT-G scores range from 0 to 4. Higher score means a better outcome. Different parts of the McGill and FACT-G tools were used to create 5 standardized z scores: McGill QOL Scale single item, McGill Psychological Well-Being sub-scale, McGill Existential Well-Being sub-scale, FACT-G Physical Functioning sub-scale and FACT-G Social Functioning sub-scale. Sum of the five standardized z-scores is the Aggregate QOL score. A higher Z score indicates better outcomes. The maximum possible Z-score ranged from -3.54 to 1.24.

Outcome measures

Outcome measures
Measure
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control
n=135 Participants
Patients will receive usual care
Aim 2 Patient Well-being
-0.01 standardized score on a scale
Standard Deviation 0.73
-0.07 standardized score on a scale
Standard Deviation 0.80

SECONDARY outcome

Timeframe: 7 months

Population: Sf-12 was given to the caregivers only.

SF-12 scores are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Outcome measures

Outcome measures
Measure
Intervention
n=48 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control
n=49 Participants
Patients will receive usual care
Caregiver Mean Overall Mental Health as Measured by the SF-12 Assessment
48.9 units on a scale
Standard Deviation 9.6
47.9 units on a scale
Standard Deviation 11.5

SECONDARY outcome

Timeframe: 3 years

Population: Health care utilization was assessed in patients only.

Patient charts were audited for 3 outcomes : 1) chemotherapy use, 2) aggressive treatments and 3) emergency department or hospital utilization. The total scores ranged from 0-6 with higher scores indicated worse outcomes. The sums of the means for the 3 outcomes were added to provide the total score.

Outcome measures

Outcome measures
Measure
Intervention
n=130 Participants
Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit. Communication training and coaching: Oncologists will receive communication training. Patients will be coached to make the most of the oncologist visit.
Control
n=135 Participants
Patients will receive usual care
Health Care Utilization- Mean Index Score of Aggressive Care at the End of Life
0.76 units on a scale
Standard Deviation 1.1
0.58 units on a scale
Standard Deviation 0.9

Adverse Events

Intervention-patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 91 deaths

Control-patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 96 deaths

Intervention- Caregivers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Intervention-caregivers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ronald Epstein MD

UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE

Phone: 5855069484

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place